Tag Archive for: United States

The Omicron subvariant XBB is expected to account for 18.3% of the COVID-19 cases in the United States, up from 11.2% in the previous week, the U.S. Centers for Disease Control and Prevention (CDC) said on Friday.

BioNTech on Friday initiated an early-stage study to evaluate its experimental malaria vaccine in humans, the German drugmaker said.

Roche has entered into a U.S. focused collaboration with Pfizer to drive awareness and educate on the importance of timely COVID-19 testing, available treatment options, symptoms, and the high-risk factors that can increase the chance of progressing to severe illness.

A former employee of a Massachusetts compounding pharmacy whose mold-tainted drugs sparked a deadly nationwide fungal meningitis outbreak in 2012 was sentenced on Tuesday to five months in prison for deceiving regulators about its operations before the tragedy.

The U.S. government agreed to pay Pfizer Inc. nearly $2 billion for an additional 3.7 million courses of its COVID-19 antiviral treatment Paxlovid, the company said on Tuesday.

Summit Therapeutics Inc. said on Tuesday it would license China-based Akeso Inc.’s experimental cancer therapy in a deal worth up to $5 billion, sending its shares up 57% in premarket trade.

Britain’s health regulator on Tuesday authorized a COVID-19 vaccine for infants as young as six months, opening the door for vaccinating the country’s youngest children once the UK’s Joint Committee on Vaccination and Immunization (JCVI) agrees.

Mpox is expected to no longer be considered a public health emergency in the United States from Feb. 1, 2023, the U.S. health department said on Friday.

The U.S. national public health agency said on Friday that Omicron subvariants BQ.1 and BQ.1.1 were estimated to account for about 44.2% of COVID-19 cases in the country for the week ending Nov. 12, compared with 32.6% in the previous week.

GSK’s oncology business suffers fresh blow with Zejula setback By Natalie Grover and Pushkala Aripaka Nov 11 (Reuters) – Britain’s GSK (GSK.L) said on Friday it would limit the use […]